Newleos Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- March 03, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $93,500,000
Company Info
- Founders
- David Donabedian
- Company Description
- Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines.
- Market
- Mental Health
- Location
- Boston, MA, United States
- Coinvestors
- Arkin Bio Ventures, DCVC Bio, Goldman Sachs, Longwood Fund, Novo Holdings